<!DOCTYPE pdf2xml SYSTEM "pdf2xml.dtd">
<pdf2xml producer="poppler" version="23.04.0">
<page number="1" position="absolute" top="0" left="0" height="792" width="612">
	<fontspec id="font0" size="8" family="AkzidenzGroteskBE-Md,Bold" color="#000000"/>
	<fontspec id="font1" size="8" family="AkzidenzGroteskBE" color="#000000"/>
	<fontspec id="font2" size="8" family="AkzidenzGroteskBE-It,Italic" color="#000000"/>
	<fontspec id="font3" size="7" family="AkzidenzGroteskBE-It,Italic" color="#000000"/>
	<fontspec id="font4" size="9" family="AkzidenzGroteskBE" color="#000000"/>
	<fontspec id="font5" size="11" family="AkzidenzGroteskBE,Bold" color="#000000"/>
	<fontspec id="font6" size="9" family="AkzidenzGroteskBE,Bold" color="#000000"/>
	<fontspec id="font7" size="6" family="AkzidenzGroteskBE" color="#000000"/>
<text top="42" left="56" width="181" height="7" font="font0" id="p1_t1" reading_order_no="0" segment_no="0" tag_type="title">Breast Cancer Research Vol 8 No 5    Preda et al.<b>Breast Cancer Research</b></text>
<text top="758" left="56" width="40" height="7" font="font1" id="p1_t2" reading_order_no="98" segment_no="19" tag_type="text">Page 2 of 9</text>
<text top="768" left="56" width="120" height="6" font="font3" id="p1_t3" reading_order_no="99" segment_no="20" tag_type="text">(page number not for citation purposes)<i>et al.</i></text>
<text top="85" left="56" width="240" height="9" font="font4" id="p1_t4" reading_order_no="1" segment_no="1" tag_type="text">To the best of our knowledge, no specific data are available on</text>
<text top="97" left="56" width="240" height="9" font="font4" id="p1_t5" reading_order_no="2" segment_no="1" tag_type="text">the accuracy of MRM to differentiate recurrent lesions from<i>(page number not for citation purposes)</i></text>
<text top="109" left="56" width="241" height="9" font="font4" id="p1_t6" reading_order_no="3" segment_no="1" tag_type="text">normal changes of the surgical scar at the site of prior lumpec-</text>
<text top="120" left="56" width="240" height="9" font="font4" id="p1_t7" reading_order_no="4" segment_no="1" tag_type="text">tomy when a multifactorial MRM evaluation protocol is used to</text>
<text top="132" left="56" width="104" height="9" font="font4" id="p1_t8" reading_order_no="5" segment_no="1" tag_type="text">classify enhancing lesions.</text>
<text top="156" left="56" width="240" height="9" font="font4" id="p1_t9" reading_order_no="6" segment_no="4" tag_type="text">This study was designed to determine whether MRM, per-</text>
<text top="167" left="56" width="240" height="9" font="font4" id="p1_t10" reading_order_no="7" segment_no="4" tag_type="text">formed with a multifactorial evaluation of enhancing lesions,</text>
<text top="179" left="56" width="240" height="9" font="font4" id="p1_t11" reading_order_no="8" segment_no="4" tag_type="text">improves the accuracy of diagnosis of recurrence on the sur-</text>
<text top="191" left="56" width="240" height="9" font="font4" id="p1_t12" reading_order_no="9" segment_no="4" tag_type="text">gical scar in patients who underwent quadrantectomy and</text>
<text top="203" left="56" width="240" height="9" font="font4" id="p1_t13" reading_order_no="10" segment_no="4" tag_type="text">local radiation therapy. Furthermore, the overall accuracy of</text>
<text top="214" left="56" width="240" height="9" font="font4" id="p1_t14" reading_order_no="11" segment_no="4" tag_type="text">contrast-enhanced MRM for the detection of suspicious</text>
<text top="226" left="56" width="240" height="9" font="font4" id="p1_t15" reading_order_no="12" segment_no="4" tag_type="text">enhancing lesions, even when not closely related to the surgi-</text>
<text top="238" left="56" width="218" height="9" font="font4" id="p1_t16" reading_order_no="13" segment_no="4" tag_type="text">cal scar, has also been assessed in the series reported.</text>
<text top="261" left="56" width="121" height="10" font="font5" id="p1_t17" reading_order_no="14" segment_no="7" tag_type="title">Materials and methods</text>
<text top="273" left="56" width="36" height="8" font="font6" id="p1_t18" reading_order_no="15" segment_no="8" tag_type="title">Patients</text>
<text top="285" left="56" width="240" height="9" font="font4" id="p1_t19" reading_order_no="16" segment_no="9" tag_type="text">The study cohort comprised 93 female patients who under-<b>Materials and methods</b></text>
<text top="297" left="56" width="240" height="9" font="font4" id="p1_t20" reading_order_no="17" segment_no="9" tag_type="text">went breast MRI examination between April 1999 and July<b>Patients</b></text>
<text top="308" left="56" width="240" height="9" font="font4" id="p1_t21" reading_order_no="18" segment_no="9" tag_type="text">2003 for suspected recurrence on the site of conservative sur-</text>
<text top="320" left="56" width="240" height="9" font="font4" id="p1_t22" reading_order_no="19" segment_no="9" tag_type="text">gery (quadrantectomy) for breast cancer, at least 6 months</text>
<text top="332" left="56" width="130" height="9" font="font4" id="p1_t23" reading_order_no="20" segment_no="9" tag_type="text">after the end of radiation therapy.</text>
<text top="355" left="56" width="240" height="9" font="font4" id="p1_t24" reading_order_no="21" segment_no="11" tag_type="text">All patients underwent a yearly breast evaluation, performed by</text>
<text top="367" left="56" width="240" height="9" font="font4" id="p1_t25" reading_order_no="22" segment_no="11" tag_type="text">the breast radiologist with mammography, associated or not</text>
<text top="379" left="56" width="240" height="9" font="font4" id="p1_t26" reading_order_no="23" segment_no="11" tag_type="text">with an ultrasound examination, according to the characteris-</text>
<text top="391" left="56" width="240" height="9" font="font4" id="p1_t27" reading_order_no="24" segment_no="11" tag_type="text">tics of the breast tissue density, and underwent a clinical</text>
<text top="402" left="56" width="241" height="9" font="font4" id="p1_t28" reading_order_no="25" segment_no="11" tag_type="text">examination. The clinical examination routinely performed by</text>
<text top="414" left="56" width="240" height="9" font="font4" id="p1_t29" reading_order_no="26" segment_no="11" tag_type="text">the breast radiologists after the evaluation of mammographic</text>
<text top="426" left="56" width="240" height="9" font="font4" id="p1_t30" reading_order_no="27" segment_no="11" tag_type="text">scans, matched in the same report of mammography, and was</text>
<text top="438" left="56" width="164" height="9" font="font4" id="p1_t31" reading_order_no="28" segment_no="11" tag_type="text">also used to decide the level of suspicion.</text>
<text top="461" left="56" width="240" height="9" font="font4" id="p1_t32" reading_order_no="29" segment_no="13" tag_type="text">Recurrence was suspected either by ultrasound or by mam-</text>
<text top="473" left="56" width="240" height="9" font="font4" id="p1_t33" reading_order_no="30" segment_no="13" tag_type="text">mography, or by both examinations. When a malignant lesion</text>
<text top="485" left="56" width="240" height="9" font="font4" id="p1_t34" reading_order_no="31" segment_no="13" tag_type="text">on the surgical scar was suspected (ultrasound and/or mam-</text>
<text top="496" left="56" width="240" height="9" font="font4" id="p1_t35" reading_order_no="32" segment_no="13" tag_type="text">mographic Breast Imaging Reporting and Data System (BI-</text>
<text top="508" left="56" width="240" height="9" font="font4" id="p1_t36" reading_order_no="33" segment_no="13" tag_type="text">RADS) III or BI-RADS IV), the patient underwent a contrast-</text>
<text top="520" left="56" width="240" height="9" font="font4" id="p1_t37" reading_order_no="34" segment_no="13" tag_type="text">enhanced breast magnetic resonance mammography (MRM),</text>
<text top="532" left="56" width="240" height="9" font="font4" id="p1_t38" reading_order_no="35" segment_no="13" tag_type="text">after signing a proper informed consent and after exclusion of</text>
<text top="543" left="56" width="190" height="9" font="font4" id="p1_t39" reading_order_no="36" segment_no="13" tag_type="text">contraindications to exposure to magnetic fields.</text>
<text top="567" left="56" width="199" height="8" font="font6" id="p1_t40" reading_order_no="37" segment_no="15" tag_type="title">Magnetic resonance mammography technique</text>
<text top="579" left="56" width="241" height="9" font="font4" id="p1_t41" reading_order_no="38" segment_no="16" tag_type="text">All MRM examinations were performed on a Signa Horizon LX</text>
<text top="590" left="56" width="240" height="9" font="font4" id="p1_t42" reading_order_no="39" segment_no="16" tag_type="text">(GE Medical Systems, Milwaukee, WI, USA), with a field<b>Magnetic resonance mammography technique</b></text>
<text top="602" left="56" width="241" height="9" font="font4" id="p1_t43" reading_order_no="40" segment_no="16" tag_type="text">strength of 1 T. The entire breast was scanned with a two-</text>
<text top="614" left="56" width="240" height="9" font="font4" id="p1_t44" reading_order_no="41" segment_no="16" tag_type="text">channel, phased-array, bilateral dedicated coil and the follow-</text>
<text top="626" left="56" width="241" height="9" font="font4" id="p1_t45" reading_order_no="42" segment_no="16" tag_type="text">ing parameters: Repetition Time = 7 ms, Echo Time = 1.6 ms,</text>
<text top="637" left="56" width="240" height="9" font="font4" id="p1_t46" reading_order_no="43" segment_no="16" tag_type="text">flip angle = 10°, TI = 25 ms, receiver bandwidth = 32 kHz,</text>
<text top="649" left="56" width="241" height="9" font="font4" id="p1_t47" reading_order_no="44" segment_no="16" tag_type="text">Number of Excitations = 1, matrix = 320 × 320, Field of View</text>
<text top="661" left="56" width="241" height="9" font="font4" id="p1_t48" reading_order_no="45" segment_no="16" tag_type="text">= 36 × 18 cm 2 . The slice thickness was chosen between 2</text>
<text top="673" left="56" width="240" height="9" font="font4" id="p1_t49" reading_order_no="46" segment_no="16" tag_type="text">mm and 3 mm, depending on the breast size, in order to main-</text>
<text top="684" left="56" width="144" height="9" font="font4" id="p1_t50" reading_order_no="47" segment_no="16" tag_type="text">tain each sequence time within 90 s.</text>
<text top="708" left="56" width="240" height="9" font="font4" id="p1_t51" reading_order_no="48" segment_no="18" tag_type="text">Coronal T1-weighted, fat-suppressed (spectral inversion at</text>
<text top="720" left="56" width="240" height="9" font="font4" id="p1_t52" reading_order_no="49" segment_no="18" tag_type="text">lipid) FSPGR 3D sequences were acquired once before and</text>
<text top="85" left="315" width="240" height="9" font="font4" id="p1_t53" reading_order_no="50" segment_no="2" tag_type="text">five times after intravenous contrast injection (Gadopentetate</text>
<text top="97" left="315" width="240" height="9" font="font4" id="p1_t54" reading_order_no="51" segment_no="2" tag_type="text">dimeglumine, 0.2 mmol/kg; flow rate = 2 ml/s). The acquisition</text>
<text top="109" left="315" width="230" height="9" font="font4" id="p1_t55" reading_order_no="52" segment_no="2" tag_type="text">of dynamic images started 10 s after the contrast injection.</text>
<text top="132" left="315" width="240" height="9" font="font4" id="p1_t56" reading_order_no="53" segment_no="3" tag_type="text">To determine the contrast medium uptake, baseline images</text>
<text top="144" left="315" width="240" height="9" font="font4" id="p1_t57" reading_order_no="54" segment_no="3" tag_type="text">were subtracted from images obtained after contrast medium</text>
<text top="156" left="315" width="240" height="9" font="font4" id="p1_t58" reading_order_no="55" segment_no="3" tag_type="text">injection. All dynamic images were sent to a diagnostic work-</text>
<text top="167" left="315" width="240" height="9" font="font4" id="p1_t59" reading_order_no="56" segment_no="3" tag_type="text">station (Advantage Window 4.2; GE Medical Systems, Mil-</text>
<text top="179" left="315" width="240" height="9" font="font4" id="p1_t60" reading_order_no="57" segment_no="3" tag_type="text">waukee, WI) where the maximum intensity projection and the</text>
<text top="191" left="315" width="150" height="9" font="font4" id="p1_t61" reading_order_no="58" segment_no="3" tag_type="text">multiplanar reformation were obtained.</text>
<text top="214" left="315" width="201" height="8" font="font6" id="p1_t62" reading_order_no="59" segment_no="5" tag_type="title">Evaluation of magnetic resonance images and</text>
<text top="226" left="315" width="101" height="8" font="font6" id="p1_t63" reading_order_no="60" segment_no="5" tag_type="title">classification of lesions</text>
<text top="238" left="315" width="240" height="9" font="font4" id="p1_t64" reading_order_no="61" segment_no="6" tag_type="text">One senior radiologist, aware of the time of surgery and the</text>
<text top="250" left="315" width="240" height="9" font="font4" id="p1_t65" reading_order_no="62" segment_no="6" tag_type="text">location of the primary breast cancer, and of the mammo-</text>
<text top="261" left="315" width="240" height="9" font="font4" id="p1_t66" reading_order_no="63" segment_no="6" tag_type="text">graphic and ultrasonographic findings, reviewed each MRM<b>Evaluation of magnetic resonance images and </b></text>
<text top="273" left="315" width="158" height="9" font="font4" id="p1_t67" reading_order_no="64" segment_no="6" tag_type="text">examination on a diagnostic workstation.<b>classification of lesions</b></text>
<text top="297" left="315" width="240" height="9" font="font4" id="p1_t68" reading_order_no="65" segment_no="10" tag_type="text">Each lesion was retrospectively reviewed and classified by the</text>
<text top="308" left="315" width="240" height="9" font="font4" id="p1_t69" reading_order_no="66" segment_no="10" tag_type="text">reader according to a multifactorial evaluation protocol for</text>
<text top="320" left="315" width="240" height="9" font="font4" id="p1_t70" reading_order_no="67" segment_no="10" tag_type="text">enhancing lesions connected or not to the surgical scar. Mor-</text>
<text top="332" left="315" width="240" height="9" font="font4" id="p1_t71" reading_order_no="68" segment_no="10" tag_type="text">phological features and time–signal intensity curves of</text>
<text top="344" left="315" width="240" height="9" font="font4" id="p1_t72" reading_order_no="69" segment_no="10" tag_type="text">enhancing lesions were classified according to the Fischer</text>
<text top="355" left="315" width="240" height="9" font="font4" id="p1_t73" reading_order_no="70" segment_no="10" tag_type="text">multifactorial evaluation [1] to differentiate malignant lesions</text>
<text top="367" left="315" width="76" height="9" font="font4" id="p1_t74" reading_order_no="71" segment_no="10" tag_type="text">and benign lesions.</text>
<text top="391" left="315" width="240" height="9" font="font4" id="p1_t75" reading_order_no="72" segment_no="12" tag_type="text">The morphological features evaluated and graded were form,</text>
<text top="402" left="315" width="240" height="9" font="font4" id="p1_t76" reading_order_no="73" segment_no="12" tag_type="text">margins and enhanced pattern. Form was considered suspi-</text>
<text top="414" left="315" width="240" height="9" font="font4" id="p1_t77" reading_order_no="74" segment_no="12" tag_type="text">cious for malignancy when it was branching or spiculated,<a href="">[1] to di</a>fferentiate malignant lesions</text>
<text top="426" left="315" width="240" height="9" font="font4" id="p1_t78" reading_order_no="75" segment_no="12" tag_type="text">whereas it was considered benign when it was rounded. Mar-</text>
<text top="438" left="315" width="240" height="9" font="font4" id="p1_t79" reading_order_no="76" segment_no="12" tag_type="text">gins were considered suspicious for malignancy if indistinct,</text>
<text top="449" left="315" width="240" height="9" font="font4" id="p1_t80" reading_order_no="77" segment_no="12" tag_type="text">while they were considered benign if well defined. The</text>
<text top="461" left="315" width="240" height="9" font="font4" id="p1_t81" reading_order_no="78" segment_no="12" tag_type="text">enhancing pattern was suspicious for malignancy if it was</text>
<text top="473" left="315" width="240" height="9" font="font4" id="p1_t82" reading_order_no="79" segment_no="12" tag_type="text">inhomogeneous or ring shaped, whereas it was considered</text>
<text top="485" left="315" width="240" height="9" font="font4" id="p1_t83" reading_order_no="80" segment_no="12" tag_type="text">benign if it was homogeneous. Lesions were accordingly</text>
<text top="496" left="315" width="240" height="9" font="font4" id="p1_t84" reading_order_no="81" segment_no="12" tag_type="text">graded on a one-point scale for form and for margins (0 =</text>
<text top="508" left="315" width="240" height="9" font="font4" id="p1_t85" reading_order_no="82" segment_no="12" tag_type="text">benign, 1 = malignant), and on a two-point scale for enhancing</text>
<text top="520" left="315" width="208" height="9" font="font4" id="p1_t86" reading_order_no="83" segment_no="12" tag_type="text">patterns (0 = benign, 1 = suspicious, 2 = malignant).</text>
<text top="543" left="315" width="240" height="9" font="font4" id="p1_t87" reading_order_no="84" segment_no="14" tag_type="text">According to the same classification of Fischer and colleagues</text>
<text top="555" left="315" width="240" height="9" font="font4" id="p1_t88" reading_order_no="85" segment_no="14" tag_type="text">[1], the dynamic course of enhancement was considered sus-</text>
<text top="567" left="315" width="240" height="9" font="font4" id="p1_t89" reading_order_no="86" segment_no="14" tag_type="text">picious for malignancy if there was an initial strong increase</text>
<text top="579" left="315" width="240" height="9" font="font4" id="p1_t90" reading_order_no="87" segment_no="14" tag_type="text">and a postinitial washout, while a moderate initial increase and</text>
<text top="590" left="315" width="240" height="9" font="font4" id="p1_t91" reading_order_no="88" segment_no="14" tag_type="text">a postinitial plateau were considered benign. Accordingly, a</text>
<text top="602" left="315" width="241" height="9" font="font4" id="p1_t92" reading_order_no="89" segment_no="14" tag_type="text">two-point scoring scale system was used both for the initial<a href="">[1],</a> the dynamic course of enhancement was considered sus-</text>
<text top="614" left="315" width="240" height="9" font="font4" id="p1_t93" reading_order_no="90" segment_no="14" tag_type="text">increase of enhancement (0 = enhancement &lt;50%, 1 = 50–</text>
<text top="626" left="315" width="240" height="9" font="font4" id="p1_t94" reading_order_no="91" segment_no="14" tag_type="text">100% enhancement, 2 = enhancement &gt;100%) and for the</text>
<text top="637" left="315" width="240" height="9" font="font4" id="p1_t95" reading_order_no="92" segment_no="14" tag_type="text">postinitial enhancement (0 = steady increase, 1 = plateau, 2 =</text>
<text top="649" left="315" width="38" height="9" font="font4" id="p1_t96" reading_order_no="93" segment_no="14" tag_type="text">washout).</text>
<text top="673" left="315" width="240" height="9" font="font4" id="p1_t97" reading_order_no="94" segment_no="17" tag_type="text">Using this multifactorial evaluation protocol, the overall maxi-</text>
<text top="684" left="315" width="240" height="9" font="font4" id="p1_t98" reading_order_no="95" segment_no="17" tag_type="text">mum score achievable is 8: a total score lower than 3 points</text>
<text top="696" left="315" width="240" height="9" font="font4" id="p1_t99" reading_order_no="96" segment_no="17" tag_type="text">indicated benign lesions, whereas a total score higher than 4</text>
<text top="708" left="315" width="135" height="9" font="font4" id="p1_t100" reading_order_no="97" segment_no="17" tag_type="text">points indicated malignant lesions.</text>
</page>
</pdf2xml>
